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LETTERS TO THE EDITOR 
Diagnostic Value of T-Cell Receptor Beta Gene Rearrangement Analysis on 
Peripheral Blood Lymphocytes of Patients with Erythroderma 
To the Editor: 
~ e read with interest the recent article by Bakels et al discussing the 
diagnostic value of gene rearrangement studies in patients with 
e.rythroderma. The authors have introduced the terms "false-posi-
t~ve and false-negative," which we feel require careful considera-
tion . 
. There are several established explanations for genuine false posi-
tive results. Partial digestions may result in fragments larger than 
the germline band but occasionally produce fragments that are 
smaller, as characterized by the 8.5-kb EcoR1 fragment frequently 
seen after hybridization with a C beta T-cell receptor probe [1] . 
Restriction fragment length polymorphisms within the T-cell re-
ceptor loci may theoretically give rise to additional discrete bands 
b.ut these can easily be distinguished by the use of a different restric-
tion ~nzyme digest or by analysis of different tissues from the same 
I11dlVldual [1] . In this study three patients with "benign" erythro-
derma had evidence of faint additional bands the authors have de-
~cribed as false positive. In two patients the most likely explanation 
IS that these bands are a consequence of partial digestion. The au-
thors ' suggestion that this is excluded by the use of an immunoglob-
ulIn .heavy chain probe is not strictly correct because the EcoR1 
restnction enzyme sites within the immunoglobulin heavy chain 
locus are physically distinct from those within the beta T-cell recep-
tor gene locus. In contrast the third patient with a " benign" er-
ythroderma had a clear-cut discrete rearranged band with both J 
beta 2 and C beta probes in EcoR1 and Bam H1 digests, respectively. 
The authors state that the histology of skin and lymph node biopsies 
Was suggestive of cutaneous T-cell lymphoma but they seem reluc-
tant to accept this result as evidence of a clonal T-cell population in 
View of the benign outcome. However, to describe this finding as a 
false-positive result is misleading. As the authors mention, clonality 
IS not synonymous with malignancy and spontaneous resolution is 
an established feature of certain cutaneous Iymphoproliferative dis-
orders that are associated with lymphoid clones [2]. Although our 
I11terpretation of such results should be cautious it would be unwise 
to choose to ignore such findings. 
I' Two of the ten patients with Sezary syndrome initially had germ-
,~ne results, which highlights additional problems of interpretation. 
False-negative" results may be a consequence of sensitivity as sug-
~ested ~or patient 9 but this explanation does not appe~r to be va.lid 
bor patient 7. Rearranged bands may co-migrate With germlme 
ands and this is particularly applicable to Bam H1 digests that 
produce large germline fragments . The routine use of a number of 
rest~iction enzymes, including Hind III, EcoRV, and Xbal, should 
jVOld this possibility in the majority of cases. In addition, T-cell 
ymp~omas including cutaneous T-cell lymphoma, may have a 
germiIne beta T-cell receptor gene configuration and a rearrange-
ment.of gamma and/or delta genes [3]. Finally, we and others have 
Identified a minority of patients with class ical features of Sezary 
syndrome in whom no clonal T-cell receptor gene rearrangements 
;ere detected despite a comprehensive analysis of beta, gamma, and 
I elta T-cell receptor genes using multiple restriction enzymes [3,4]. 
n fact these may represent genuine "false-negative" results because 
cytogenetic studies in some of these patients have indicated the 
presence of a clonal karyotype [4]. It has been suggested that this 
hay be a consequence of deletion of T-cell receptor genes within 
:h e neoplastic clone but at present there is no evidence to support 
IS explanation. 
Analysis ofT-cell receptor genes will have increasing diagnostic 
and prognostic significance for the management of patients with 
cutaneous T-cell lymphomas. Therefore it is essential that we 
clearly define criteria for the interpretation of false-positive and 
false-negative results. 
Sean J. Whittaker 
Neil P. Smith 
St. John's Dermatology Centre 
St. Thomas's Hospital 
London, England 
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REPLY 
We agree with Whittaker and Smith that the terms "false negative" 
and "false positive" as used in our study require careful considera-
tion. The primary goal of our study was to define the specificity and 
sensitivity of a new diagnostic parameter, i.e., demonstration of 
clonal T-cell receptor beta (TCRP) gene rearrangements in periph-
eral blood by means of Southern blot analysis, in the diagnosis of 
Sezary's syndrome (SS). Therefore two well-defined groups of pa-
tients with erythroderma were investigated: a malignant group of 
10 patients with clearcut SS, as defined by clinical, histologic, cyto-
logic, immunologic, and morphometric criteria; and a benign group 
of 19 patients that did not meet with these criteria for SS [1] . If all 
benign cases had shown a germline configuration and all SS patients 
a clonal rearrangement our conclusion would have been that this 
particular technique has a sensitivity and specificity of 100% in the 
diagnosis of SS. However, in case such a new diagnostic parameter 
yields negative results in patients with well-established SS (two of 
ten cases in our study) and positive results in patients that do not 
meet our criteria for ss (one of 19 patients), implicating a sensitivity 
and specificity less than 100%, we felt and still feel it is appropriate 
to use the terms "false negative" and "false positive," respectively, 
for these results. Perhaps it is useful to emphasize once again that the 
parameter tested in our study was not clonality per se, but demon-
stration of clonal rearrangements of the TCRP gene by Southern 
blot analysis performed in the appropriate way, i.e., by using several 
restriction enzymes and more than one probe. It is for this reason the 
terms "false negative" and "false positive" were placed between 
quotation marks. We agree with Whittaker and Smith that the 
"false-negative" and "false-positive" results in our study are not 
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